Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: harsh (4), strict (49), acute (409)

Papers Trust Board - 15 July 2025

Description: Agenda Trust Board – Open Session Date 15/07/2025 Time 9:00 - 13:00 Location Conference Room, Heartbeat Education Centre Chair
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2025-Trust-documents/Papers-Trust-Board-15-July-2025.pdf

Semaglutide for weight management in children - patient information

Description: This factsheet explains what semaglutide is, and what the potential benefits and risks of taking it are.
Url: /Media/UHS-website-2019/Patientinformation/Childhealth/Semaglutide-for-weight-management-in-children-3182-PIL.pdf

Liraglutide for weight management in children - patient information

Description: This factsheet explains what liraglutide is, and what the potential benefits and risks of taking it are.
Url: /Media/UHS-website-2019/Patientinformation/Childhealth/Liraglutide-for-weight-management-in-children-3181-PIL.pdf

Having a tunnelled cuffed central venous catheter (TCVC) for parenteral support - patient information

Description: This factsheet explains what you need to know about having a tunnelled cuffed central venous catheter (TCVC) for parenteral support.
Url: /Media/UHS-website-2019/Patientinformation/Surgery/Having-a-tunnelled-cuffed-central-venous-catheter-TCVC-for-parenteral-support-3901-PIL.pdf

Magnetic resonance imaging (MRI) arthrogram - patient information

Description: This factsheet explains what a magnetic resonance imaging (MRI) arthrogram is and what to expect at your appointment.
Url: /Media/UHS-website-2019/Patientinformation/Scansandx-rays/Magnetic-resonance-imaging-MRI-arthrogram-3826-PIL.pdf

InP IVE-Epirubicin-Etoposide-Ifosfamide Ver1.1

Description: Chemotherapy Protocol LYMPHOMA EPIRUBICIN-ETOPOSIDE-IFOSFAMIDE (IVE) Inpatient Regimen Regimen • Lymphoma – InP-IVE-Epirubicin-Etoposide-Ifosfamide Indi
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/InP-IVE-Epirubicin-Etoposide-Ifosfamide.pdf

Lisocel – Cyclophosphamide (300) – Fludarabine (30) Ver1

Description: Chemotherapy Protocol CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY LISOCEL – CYCLOPHOSPHAMIDE (300) – FLUDARABINE (30) This regimen will only be available t
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Lisocel-–-Cyclophosphamide-300-–-Fludarabine-30.pdf

Preventing infection - patient information

Description: Preventing infection Information for patients 3 At University Hospital Southampton NHS Foundation Trust (UHSFT) we take infection p
Url: /Media/UHS-website-2019/Patientinformation/Visitinghospital/Preventinginfection-patientinformation.pdf

Epcoritamab -Cycle 2 (Onwards)

Description: Chemotherapy Protocol LYMPHOMA EPCORITAMAB – Cycle 2 Onwards - (28 day) Regimen • Lymphoma-Epcoritamab – Cycle 2 Onwards - (28 day) Ind
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Epcoritamab-Cycle-2-Onwards-Ver1.pdf

Epcoritamab -Cycle 1 (Priming)

Description: Chemotherapy Protocol LYMPHOMA EPCORITAMAB -Cycle 1 - (28 Day -Priming) Regimen • Lymphoma-Epcoritamab – Cycle 1- (28 day -Priming) Ind
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Epcoritamab-Cycle-1-Priming-Ver1.pdf

591 to 600 of 726

Previous … 58 59 60 61 62 … Next